Top compounds associated with response to CP


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.038 0.3
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA azacitidine CTRPv2 pan-cancer AAC -0.041 0.3
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC 0.083 0.3
mRNA SCH-529074 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA PI-103 GDSC1000 pan-cancer AAC -0.032 0.3
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC 0.058 0.3
mRNA IOX2 GDSC1000 pan-cancer AAC 0.035 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
Download CSV